About myrexis inc - MYRX
Myrexis, Inc. is in the process of evaluating strategic alternatives, including focusing on identifying, evaluating, and making financial investments in life sciences assets. The company was founded in January 2009 and is headquartered in New York, NY.
MYRX At a Glance
Myrexis, Inc.
600 Fifth Avenue
New York, New York 10020
| Phone | 1-801-214-7800 | Revenue | 0.00 | |
| Industry | Financial Conglomerates | Net Income | -11,621,000.00 | |
| Sector | Finance | Employees | 1 | |
| Fiscal Year-end | 06 / 2014 | |||
| View SEC Filings |
MYRX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 2.224 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.093 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
MYRX Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -11,621,000.00 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
MYRX Liquidity
| Current Ratio | 16.716 |
| Quick Ratio | 16.716 |
| Cash Ratio | 16.351 |
MYRX Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -25.022 |
| Return on Equity | -25.672 |
| Return on Total Capital | -999.226 |
| Return on Invested Capital | -25.672 |
MYRX Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |